4D Biomaterials is a UK medical-technology company developing bioresorbable polymer materials for medical devices and tissue-engineering applications. Its materials are intended to support applications such as 3D-printed implants and regenerative medicine, serving medical-device manufacturers and healthcare markets.
Subscribe to see 4D Biomaterials’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A few of 4D Biomaterials's closest competitors — see the full list of competitors and alternatives →
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Particle3D is a Danish medical-technology company developing patient-specific, 3D-printed biodegradable bone implants made from calcium-phosphate materials. Its products are intended for hospitals and surgeons treating bone defects, including in orthopedic and reconstructive applications.
Healshape is a regenerative medicine startup headquartered in Lyon, France, founded in 2020 to develop 3D bioprinted breast implants for innovative breast reconstruction.
Polyganics B.V. is a medical technology company based in Groningen, Netherlands, that specializes in developing synthetic polymer bioresorbable surgical devices. In 2022, the company was acquired by Regenity to expand its horizons in the life sciences sector.
Noraker is a pioneering startup located in Lyon, France, specializing in regenerative medicine and orthopedics. The company designs, manufactures, and markets biomaterial-based implants aimed at preserving bone quality and promoting bone reconstruction.
Plexaa is a UK-based MedTech company that develops medical devices and digital products to improve surgical outcomes. Its flagship offering is BLOOM43, a wearable, sensor-controlled thermal preconditioning device paired with a companion app designed to prepare the skin before breast surgery and optimize recovery.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.